Utilization of molecular resistance test results as tools to support public health efforts for improved control of rifampicin resistant tuberculosis Instituut voor Tropische Geneeskunde
Frank G.J. Cobbelens, Bouke de Jong
The World Health Organization (WHO) has declared tuberculosis (TB) as the infectious disease with the highest mortality worldwide, resulting in 1.8 million deaths in 2015 despite development of potent antibiotics and vaccine [1, 2]. TB places its heaviest burden on the poorest and most vulnerable populations globally, aggravating existing inequity [3]. Management of the disease has been continually challenged by the emergence of antimicrobial ...